• Citer

Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial

par Ferreira, Arlindo A.R.;Ferreira, Sofia Cristóvão;Lambertini, Matteo ;Maurer, Christian;Martel, Samuel;Costa, Luís;Pondé, Noam;de Azambuja, Evandro
Référence European journal of cancer, 144, page (351-359)
Publication Publié, 2021-02-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial
Auteur:	Ferreira, Arlindo A.R.; Ferreira, Sofia Cristóvão; Lambertini, Matteo; Maurer, Christian; Martel, Samuel; Costa, Luís; Pondé, Noam; de Azambuja, Evandro
Informations sur la publication:	European journal of cancer, 144, page (351-359)
Statut de publication:	Publié, 2021-02-01
Sujet CREF:	Cancérologie
Mots-clés:	Advanced breast cancer
	Diarrhea
	Dual blockade
	HER2
	Pertuzumab
	Predictive markers
	Prognostic markers
	Rash
	Trastuzumab
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2020.11.023
	info:pii/S0959804920313605
	info:scp/85098556311
	info:pmid/33388492